Volato Group stock soars after M2i Global acquisition announcement

Investing.com -- Volato Group Inc (NYSE: SOAR) stock jumped up to 20% on Tuesday following the announcement of a definitive business combination agreement to acquire M2i Global Inc (OTC: MTWO), a company specializing in critical minerals supply chain development.

The transaction will transform Volato from a private aviation company into a diversified industrial platform serving multiple sectors, from aviation technology to critical minerals essential for U.S. national defense and infrastructure. Under the agreement, M2i Global shareholders will own approximately 85% of the combined company, while current Volato shareholders will retain about 15%.

No cash payment will be required from Volato to complete the transaction. Based on current market prices, the structure represents an increase in value for Volato shareholders while providing M2i Global with an NYSE American listing and public market access.

Upon closing, Volato's current CEO Matt Liotta will transition to president of the aviation technology business lines, while Major General (Ret.) Alberto Rosende will become CEO of the combined entity. Mark Heinen will remain as CFO, and Mike Prachar will continue as COO.

"This transaction brings those capabilities to a new platform with significant upside, and we're confident in our ability to help accelerate growth and deliver value in the public markets," said Liotta.

The merger creates a dual-platform company focused on critical minerals infrastructure and aviation software. Volato reported Q1 2025 revenue of $25.5 million with $0.5 million in net income from continuing operations, and expects Q2 2025 revenue of approximately $25 million with net income between $3 million and $4 million.

M2i Global brings strategic partnerships including an exclusive offtake agreement with NT Minerals Limited for 88,000 tonnes of copper, valued at approximately $850 million based on current prices.

You May Also Be Interested In

• Goldman Sachs Reiterates Buy Rating on O'Reilly Automotive (ORLY)
• Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
• BioMarin completes acquisition of Amicus Therapeutics